Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389
Clinical trial NCT04322032 · UNKNOWN
Trial details
- NCT number
- NCT04322032
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-06
- Primary completion
- 2020-05-12
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.